1607 Dominion Centre, 43 Queens Road East, Wanchai, Hong Kong

EX-10.1 2 a05-15014_1ex10d1.htm EX-10.1

Exhibit 10.1

 

CHINA KANGTAI CACTUS BIO-TECH COMPANY LIMITED
AND SUBSIDIARY

 

FINANCIAL STATEMENTS
AS OF DECEMBER 31, 2004 (CONSOLIDATED) AND 2003

 



 

CHINA KANGTAI CACTUS BIO-TECH COMPANY LIMITED
AND SUBSIDIARY

 

CONTENTS

 

Report of Independent Registered Public Accounting Firm

 

 

 

Balance Sheets as of December 31, 2004 (Consolidated) and 2003

 

 

 

Statements of Operations and Comprehensive income for the years ended December 31, 2004 (Consolidated) and 2003

 

 

 

Statements of Stockholders’ Equity for the years ended December 31, 2004 (Consolidated) and 2003

 

 

 

Statements of Cash Flows for the years ended December 31, 2004 (Consolidated) and 2003

 

 

 

Notes to the Consolidated Financial Statements

 

 



 

Jimmy C.H. Cheung & Co

Certified Public Accountants

(A member of Kreston International)

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Board of Directors of:

China Kangtai Cactus Bio-tech Company Limited and subsidiary

 

We have audited the accompanying balance sheets of China Kangtai Cactus Bio-tech Company Limited and subsidiary, as of December 31, 2004 (Consolidated) and 2003 and the related statements of operations and comprehensive income, stockholders’ equity and cash flows for the years ended December 31, 2004 (Consolidated) and 2003. These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements based on our audits.

 

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits of the financial statements provide a reasonable basis for our opinion.

 

In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of China Kangtai Cactus Bio-tech Company Limited, as of December 31, 2004 (Consolidated) and 2003, and the profits of its operations and its cash flows for the years ended December 31, 2004 (Consolidated) and 2003, in conformity with accounting principles generally accepted in the United States of America.

 

JIMMY C.H. CHEUNG & CO

Certified Public Accountants

 

Hong Kong

 

Date: January 28, 2005, except for Note 12, which the date is June 10, 2005

 

 

 

1607 Dominion Centre, 43 Queen’s Road East, Wanchai, Hong Kong

 

 

 

Tel: (852) 25295500 Fax: (852) 28651067 Email: ***@***

 

 

 

Website: http://www.jimmycheungco.com

 

 

1



 

CHINA KANGTAI CACTUS BIO-TECH COMPANY LIMITED
AND SUBSIDIARY

 

BALANCE SHEETS
AS OF DECEMBER 31, 2004 (CONSOLIDATED) AND 2003

 

 

 

Note

 

2004

 

2003

 

 

 

 

 

(Consolidated)

 

 

 

 

 

 

 

 

 

 

 

ASSETS

 

CURRENT ASSETS

 

 

 

 

 

 

 

Cash and cash equivalents

 

 

 

$

701,234

 

$

142,398

 

Accounts receivable, net of allowances

 

2

 

429,866

 

386,801

 

Due from a related company

 

 

 

845,411

 

809,179

 

Due from a stockholder

 

 

 

 

4,831

 

Inventories, net

 

3

 

3,960,319

 

2,783,266

 

Other receivables

 

 

 

36,147

 

31,316

 

Total Current Assets

 

 

 

5,972,977

 

4,157,791

 

 

 

 

 

 

 

 

 

PROPERTY AND EQUIPMENT, NET

 

4

 

4,649,792

 

4,780,743

 

 

 

 

 

 

 

 

 

OTHER ASSETS

 

 

 

 

 

 

 

Intangible assets

 

5

 

827,536

 

940,580

 

Land use rights, net

 

 

 

55,658

 

56,865

 

TOTAL ASSETS

 

 

 

$

11,505,963

 

$

9,935,979

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

 

CURRENT LIABILITIES

 

 

 

 

 

 

 

Accounts payable

 

 

 

$

159,971

 

$

152,356

 

Other payables and accrued liabilities

 

6

 

282,210

 

59,620

 

Notes payable

 

7

 

730,677

 

1,213,769

 

Other taxes payable

 

 

 

27

 

 

Value added tax payables

 

 

 

666,075

 

294,853

 

Total Current Liabilities

 

 

 

1,838,960

 

1,720,598

 

 

 

 

 

 

 

 

 

COMMITMENTS AND CONTINGENCIES

 

 

 

 

 

 

 

 

 

 

 

 

 

STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

 

$1.00 par value, 20,000,000 shares authorized, 500,000 shares issued and outstanding

 

9

 

500,000

 

500,000

 

Additional paid-in capital

 

 

 

4,702,559

 

4,202,559

 

Retained earnings

 

 

 

 

 

 

 

Unappropriated

 

 

 

3,701,862

 

2,612,768

 

Appropriated

 

 

 

696,182

 

459,474

 

Due to stockholders

 

 

 

66,400

 

440,580

 

Total Stockholders’ Equity

 

 

 

9,667,003

 

8,215,381

 

 

 

 

 

 

 

 

 

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

$

11,505,963

 

$

9,935,979

 

 

The accompanying notes are an integral part of these financial statements

 

2



 

CHINA KANGTAI CACTUS BIO-TECH COMPANY LIMITED
AND SUBSIDIARY

 

STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME
FOR THE YEARS ENDED DECEMBER 31, 2004 (CONSOLIDATED) AND 2003

 

 

 

2004

 

2003

 

 

 

(Consolidated)

 

 

 

 

 

 

 

 

 

NET SALES

 

$

6,447,510

 

$

5,264,792

 

 

 

 

 

 

 

COST OF SALES

 

(4,257,305

)

(3,506,952

)

 

 

 

 

 

 

GROSS PROFIT

 

2,190,205

 

1,757,840

 

 

 

 

 

 

 

OPERATING EXPENSES

 

 

 

 

 

Selling expenses

 

298,165

 

221,826

 

General and administrative expenses

 

239,550

 

250,196

 

Professional fees

 

298,424

 

3,527

 

Depreciation

 

14,379

 

8,841

 

Amortization of land use rights

 

1,207

 

1,207

 

Amortization of intangible assets

 

113,044

 

113,043

 

Total Operating Expenses

 

964,769

 

598,640

 

 

 

 

 

 

 

INCOME FROM OPERATIONS

 

1,225,436

 

1,159,200

 

 

 

 

 

 

 

OTHER INCOME (EXPENSES)

 

 

 

 

 

Government grant

 

121,980

 

95,411

 

Interest income

 

180

 

136

 

Interest expenses

 

(21,543

)

(17,137

)

Other expenses

 

(251

)

(184

)

Total Other Income

 

100,366

 

78,226

 

 

 

 

 

 

 

INCOME FROM OPERATIONS BEFORE TAXES

 

1,325,802

 

1,237,426

 

 

 

 

 

 

 

INCOME TAX EXPENSE

 

 

 

 

 

 

 

 

 

NET INCOME

 

1,325,802

 

1,237,426

 

 

 

 

 

 

 

OTHER COMPREHENSIVE LOSS

 

 

 

 

 

Foreign currency translation loss

 

 

 

 

 

 

 

 

 

COMPREHENSIVE INCOME

 

$

1,325,802

 

$

1,237,426

 

 

 

 

 

 

 

Net income per share-basic and diluted

 

$

2.65

 

$

2.47

 

 

 

 

 

 

 

Weighted average number of shares outstanding during the year- basis and diluted

 

500,000

 

500,000

 

 

The accompanying notes are an integral part of these financial statements

 

3



 

CHINA KANGTAI CACTUS BIO-TECH COMPANY LIMITED

AND SUBSIDIARY

STATEMENTS OF SHAREHOLDERS’ EQUITY

FOR THE YEARS ENDED DECEMBER 31, 2004 (CONSOLIDATED) AND 2003

 

 

 

 

 

 

 

Additional

 

Unappropriated

 

Appropriated

 

 

 

 

 

 

 

Common Stock

 

paid-in

 

retained

 

retained

 

Due to

 

 

 

 

 

Shares

 

Amount

 

capital

 

earnings

 

earnings

 

stockholders

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at December 31, 2002

 

500,000

 

$

500,000

 

$

4,202,559

 

$

1,560,956

 

$

273,860

 

$

440,580

 

$

6,977,955

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income for the year

 

 

 

 

1,237,426

 

 

 

1,237,426

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Transfer of statutory and staff welfare reserves

 

 

 

 

(185,614

)

185,614

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at December 31, 2003

 

500,000

 

500,000

 

4,202,55 9

 

2,612,768

 

459,474

 

440,580

 

8,215,381

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contribution by stockholders

 

 

 

500,000

 

 

 

 

500,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income for the year

 

 

 

 

1,325,802

 

 

 

1,325,802

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Repayment

 

 

 

 

 

 

(374,180

)

(374,180

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Transfer of statutory and staff welfare reserves

 

 

 

 

(236,708

)

236,708

 

 

 

Balance at December 31, 2004 (Consolidated)

 

500,000

 

$

500,000

 

$

4,702,559

 

$

3,701,862

 

$

696,182

 

$

66,400

 

$

9,667,003

 

 

The accompanying are an integral part of these financial statements

 

4



 

CHINA KANGTAI CACTUS BIO-TECH COMPANY LIMITED
AND SUBSIDIARY

STATEMENTS OF CASH FLOWS
FOR THE YEARS ENDED DECEMBER 31, 2004 (CONSOLIDATED) AND 2003

 

 

 

2004

 

2003

 

 

 

(Consolidated)

 

 

 

CASH FLOWS FROM OPERATING ACTIVITIES

 

 

 

 

 

Net income

 

$

1,325,802

 

$

1,237,426

 

Adjusted to reconcile net income to cash provided by operating activities:

 

 

 

 

 

Depreciation - cost of sales

 

313,434

 

250,128

 

Depreciation-operating expenses

 

14,379

 

8,841

 

Amortization of land use rights

 

1,207

 

1,207

 

Amortization of intangible assets

 

113,044

 

113,043

 

Provision for doubtful debts

 

38,530

 

21,999

 

Changes in operating assets and liabilities (Increase) decrease in:

 

 

 

 

 

Accounts receivable, net allowances

 

(81,595

)

(153,368

)

Other receivable and prepaid expenses

 

(4,831

)

(906

)

Inventories

 

(1,177,053

)

(371,970

)

Increase (decrease) in:

 

 

 

 

 

Accounts payable

 

7,615

 

(115,002

)

Other payables and accrued liabilities

 

222,590

 

18,954

 

Other tax payables

 

27

 

 

Value added tax payables

 

371,222

 

294,615

 

Net cash provided by operating activities

 

1,144,371

 

1,304,967

 

 

 

 

 

 

 

CASH FLOWS FROM INVESTING ACTIVITIES

 

 

 

 

 

Purchase of property and equipment

 

(196,862

)

(860,889

)

Net cash used in investing activities

 

(196,862

)

(860,889

)

 

 

 

 

 

 

CASH FLOWS FROM FINANCING ACTIVITIES

 

 

 

 

 

Proceeds from issuance of common stock

 

500,000

 

 

Due from a stockholder

 

4,831

 

(4,831

)

Due from a related company

 

(36,232

)

(809,179

)

Due to stockholders

 

(374,180

)

 

Notes payable

 

(483,092

)

416,668

 

Net cash used in financing activities

 

(388,673

)

(397,342

)

 

 

 

 

 

 

NET INCREASE IN CASH AND CASH EQUIVALENTS

 

558,836

 

46,736

 

 

 

 

 

 

 

CASH AND CASH EQUIVALENTS AT BEGINNING OF YEAR

 

142,398

 

95,662

 

 

 

 

 

 

 

CASH AND CASH EQUIVALENTS AT END OF YEAR

 

$

701,234

 

$

142,398

 

 

 

 

 

 

 

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION

 

 

 

 

 

Cash paid for interest expenses

 

$

21,543

 

$

17,137

 

 

The accompanying notes are an integral part of these financial statements

 

5



 

CHINA KANGTAI CACTUS BIO-TECH COMPANY LIMITED
AND SUBSIDIARY

NOTES TO THE FINANCIAL STATEMENTS

AS OF DECEMBER 31, 2004 (CONSOLIDATED) AND 2003

 

1.     SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND ORGANIZATION

 

(A)    Organization

 

China Kangtai Cactus Bio-tech Company Limited (“China Kangtai”) was incorporated in the British Virgin Islands (“BVI”) on November 26, 2004. Harbin Hainan Kangda Cacti Hygienical Foods Joint-Stock Co., Ltd. (“Harbin Hainan Kangda”) was incorporated in the People’s Republic of China (“PRC”) on December 30, 1998 as a company with limited liability and restructured as a joint stock company on July 7, 2004 under the laws of PRC.

 

China Kangtai is an investment holding company and Harbin Hainan Kangda’s principal activities are planting cactus, developing new types of cactus, producing and trading of cactus health foods and related products in the PRC.

 

During 2004, Harbin Hainan Kangda’s shareholders exchanged 100% of their ownership of Harbin Hainan Kangda for 500,000 shares of China Kangtai under a reorganization plan. The transfer has been accounted for as a reorganization of entities under common control as the companies were beneficially owned by principally identical stockholders and share common management.  The financial statements have been prepared as if the reorganization had occurred retroactively.  China Kangtai and Harbin Hainan Kangda are hereafter referred to as (the “Company”)

 

(B)     Principles of consolidation

 

The accompanying consolidated financial statements for 2004 include the accounts of the Company and its wholly owned subsidiary, Harbin Hainan Kangda. The financial statements for 2003 include the accounts of Harbin Hainan Kangda. All significant inter-company accounts and transactions have been eliminated on consolidation.

 

(C)     Use of estimates

 

The preparation of the financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

(D)    Cash and cash equivalents

 

For purpose of the statements of cash flows, cash and cash equivalents include cash on hand and demand deposits with a bank with a maturity of less than 3 months.

 

(E)     Accounts receivable

 

The Company extends unsecured credit to its customers in the ordinary course of business but mitigates the associated risks by performing credit checks and actively pursuing past due accounts.  An allowance for doubtful accounts is established and recorded based on managements’ assessment of the credit history with the customer and current relationships with them.

 

(F)     Inventories

 

Inventories are stated at lower of cost or market value, cost being determined on a first in first out method.  The Company provided inventory allowances based on excess and obsolete inventories determined principally by customer demand.

 

6



 

(G)     Property and equipment

 

Property and equipment are stated at cost, less accumulated depreciation.  Expenditures for additions, major renewals and betterments are capitalized and expenditures for maintenance and repairs are charged to expense as incurred.

 

Depreciation is provided on a straight-line basis, less estimated residual value over the assets’ estimated useful lives.  The estimated useful lives are as follows:

 

Buildings

 

40 Years

 

Plant and machinery

 

12 Years

 

Motor vehicles

 

10 Years

 

Furniture, fixtures and equipment

 

8 Years

 

 

Land use rights are stated at cost, less accumulated amortization and are amortized over the term of the relevant rights of 50 years from the date of acquisition.

 

(H)    Long-lived assets

 

In accordance with Statement of Financial Accounting Standards No. 144, “Accounting for the impairment or disposal of Long-Lived Assets”, long-lived assets and certain identifiable intangible assets held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. For purposes of evaluating the recoverability of long-lived assets, the recoverability test is performed using undiscounted net cash flows related to the long- lived assets. The Company reviews long-lived assets to determine that carrying values are not impaired.

 

(I)      Fair value of financial instruments

 

Statement of Financial Accounting Standards No. 107, “Disclosure About Fair Value of Financial Instruments,” requires certain disclosures regarding the fair value of financial instruments. Trade accounts receivable, accounts payable, and accrued liabilities are reflected in the financial statements at fair value because of the short-term maturity of the instruments.

 

(J)      Intangible assets

 

Under the Statement of Accounting Standards (“SFAS”) No. 142, “Goodwill and Other Intangible Assets”, all goodwill and certain intangible assets determined to have indefinite lives will not be amortized but will be tested for impairment at least annually.  Intangible assets other than goodwill will be amortized over their useful lives of 10 years and reviewed for impairment in accordance with SFAS No. 144, “Accounting for Impairment or Disposal of Long-Lived Assets”.

 

(K)    Revenue recognition

 

The Company recognizes revenue upon delivery or shipment of the products, at which time title passes to the customer provided that: there are no uncertainties regarding customer acceptance; persuasive evidence of an arrangement exists; the sales price is fixed or determinable; and collectability is deemed probable.

 

The local agricultural department in Harbin, PRC approved a grant to the Company to encourage the planting of cactus. The Company recognizes the grant as revenue upon receipt from the local government.

 

7



 

(L)     Income taxes

 

PRC income tax is computed according to the relevant laws and regulations in the PRC.  The Company is organized in the People’s Republic of China and no tax benefit is expected from the tax credits in the future. The Company located its factories in a special economic region in China. This economic region allows these enterprises a two-year income tax exemption beginning in the December 2002 after they become profitable and a 50% income tax reduction for the following three years. No income tax expense has been recorded for 2004 and 2003 as the Company was exempt under the special economic region rules.

 

(M)   Foreign currency translation

 

The functional currency of the Company is the Chinese Renminbi (“RMB”).  Transactions denominated in currencies other than RMB are translated into United States dollars using year end exchange rates as to assets and liabilities and average exchange rates as to revenues and expenses.  Capital accounts are translated at their historical exchange rates when the capital transaction occurred.  Net gains and losses resulting from foreign exchange translations are included in the statements of operations and stockholder’s equity as other comprehensive income (loss). Cumulative translation adjustment amounts were insignificant at and for the years ended December 31, 2004 and 2003 as the RMB is pegged to the United States dollar.

 

(N)    Comprehensive income

 

The foreign currency translation gain or loss resulting from translation of the financial statements expressed in RMB to United States Dollar is reported as other comprehensive income (loss) in the statements of operations and stockholders’ equity. Cumulative translation adjustment amounts were insignificant and for the years ended December 31, 2004 and 2003.

 

(O)    Income share

 

Basic income per share is computed by dividing income available to common stockholders by the weighted average number of common shares outstanding during the year.  Diluted income per share is computed similar to basic income per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. There are no potentially dilutive securities for 2004 and 2003.

 

(P)     Segments

 

The Company operates in only one segment, thereafter segment disclosure is not presented.

 

(Q)    Recent Accounting Pronouncements

 

Statement of Financial Accounting Standards (“SFAS”) No. 151, “Inventory Costs – an amendment of ARB No. 43, Chapter 4”“ SFAS No. 152, “Accounting for Real Estate Time-Sharing Transactions - an amendment of FASB Statements No. 66 and 67,” SFAS No. 153, “Exchanges of Non-monetary Assets – an amendment of APB Opinion No. 29,” and SFAS No. 123 (revised 2004), “Share-Based Payment,” were recently issued.  SFAS No. 151, 152, 153 and 123 (revised 2004) have no current applicability to the Company and have no effect on the financial statements.

 

8



 

2.     ACCOUNTS RECEIVABLE

 

Accounts receivable at December 31, 2004 and 2003 consisted of the following:

 

 

 

2004

 

2003

 

 

 

 

 

 

 

Accounts receivable

 

$

490,395

 

$

408,800

 

Less: allowance for doubtful accounts

 

(60,529

)

(21,999

)

Accounts receivable, net

 

$

429,866

 

$

386,801

 

 

For the years ended December 31, 2004 and 2003, provision for doubtful accounts recorded by the Company was $38,530 and $21,999 respectively.

 

3.     INVENTORIES

 

Inventories at December 31, 2004 and 2003 consisted of the following:

 

 

 

2004

 

2003

 

 

 

 

 

 

 

Cactus stock

 

$

3,486,358

 

$

2,718,914

 

Work-in-progress

 

12,012

 

38,626

 

Finished goods

 

461,949

 

25,726

 

 

 

3,960,319

 

2,783,266

 

Less: provision of obsolescence

 

 

 

 

 

$

3,960,319

 

$

2,783,266

 

 

For the years ended December 31, 2004 and 2003, no provision for obsolete inventories was recorded by the Company.

 

4.     PROPERTY AND EQUIPMENT

 

The following is a summary of property and equipment at December 31:

 

 

 

2004

 

2003

 

 

 

 

 

 

 

Buildings

 

$

3,887,142

 

$

3,887,142

 

Plant and machinery

 

1,331,045

 

1,260,282

 

Motor vehicles

 

211,588

 

87,818

 

Furniture and office equipment

 

10,995

 

8,667

 

 

 

5,440,770

 

5,243,909

 

Less: accumulated depreciation

 

790,978

 

463,166

 

Property and equipment, net

 

$

4,649,792

 

$

4,780,743

 

 

Depreciation expenses for the years ended December 31, 2004 and 2003 were $327,813 and $258,969 respectively.

 

9



 

5.     INTANGIBLE ASSETS

 

Intangible assets related to registered patent rights and formulations of various cactus health and pharmaceutical products acquired by the Company from third parties; $888,889 were first acquired by the stockholders and injected into the Company at cost as registered capital in 2002 (note 9(A)) and $241,546 were acquired from third parties in 2002.

 

 

 

2004

 

2003

 

 

 

 

 

 

 

Patents

 

$

1,130,435

 

$

1,130,435

 

Less: accumulated amortization

 

302,899

 

189,855

 

 

 

$

827,536

 

$

940,580

 

 

 

The intangible assets are amortized over ten years on a straight line basis.  The amortization expense for both 2004 and 2003 was $113,044 and 113,043, respectively.

 

6.     OTHER PAYABLES AND ACCRUED LIABILITIES

 

Other payables and accrued liabilities at December 31, 2004 and 2003 consist of the following:

 

 

 

2004

 

2003

 

 

 

 

 

 

 

Other payables

 

$

12,078

 

$

12,078

 

Accrued liabilities

 

72,817

 

47,542

 

Professional fees due

 

197,315

 

 

 

 

$

282,210

 

$

59,620

 

 

7.     NOTES PAYABLE

 

Balance at December 31:

 

 

 

2004

 

2003

 

Note payable to a bank, interest rate of 5.7525% per annum, unsecured, due June, 2004

 

$

 

$

483,092

 

Note payable to a third party, unsecured, interest-free, due on demand

 

730,677

 

730,677

 

 

 

$

730,677

 

$

1,213,769

 

 

8.     COMMITMENTS AND CONTINGENCIES

 

(A)    Employee benefits

 

The full time employees of the Company are entitled to employee benefits including medical care, welfare subsidies, unemployment insurance and pension benefits through a Chinese government mandated multi-employer defined contribution plan. The Company is required to accrue for those benefits based on certain percentages of the employees’ salaries and make contributions to the plans out of the amounts accrued for medical and pension benefits.  The total provisions and contributions made for such employee benefits was $5,757 and $4,618 for the years ended December 31, 2004 and 2003, respectively. The Chinese government is responsible for the medical benefits and the pension liability to be paid to these employees.

 

10



 

(B)     Operating leases commitments

 

The Company leases office and land spaces from third parties under fourteen operating leases which expire from April 8, 2005 to September 20, 2030.

 

As at December 31, 2004, the Company has outstanding commitments with respect to the above non-cancelable operating leases, which are due as follows:

 

2005

 

$

139,280

 

2006

 

99,073

 

2007

 

47,238

 

2008

 

4,967

 

2009

 

1,440

 

Thereafter

 

51,695

 

 

 

$

343,693

 

 

9.     SHAREHOLDERS’ EQUITY

 

(A)    Registered capital

 

In accordance with the Articles of Association of the Company, the registered capital of the Company at the date of incorporation of December 30, 1998 was $241,546 (RMB2,000,000) which was fully paid on December 8, 1998 in cash by the shareholders. The registered capital of the Company was subsequently increased to $4,444,444 (RMB36,800,000) by an increase of $4,202,898 (RMB34,800,000) on April 18, 2000. The increase in registered capital was paid for by the contribution of four patents transferred to the Company amounting to $888,889 (RMB7,360,000) in lieu of cash and the remaining balance has been fully paid in cash.

 

(B)     Appropriated retained earnings

 

The Company’s subsidiary, Harbin Hainan Kanda is required to make appropriations to reserves funds, comprising the statutory surplus reserve, statutory public welfare fund and discretionary surplus reserve, based on after-tax net income determined in accordance with generally accepted accounting principles of the People’s Republic of China (the “PRC GAAP”).  Appropriation to the statutory surplus reserve should be at least 10% of the after tax net income determined in accordance with the PRC GAAP until the reserve is equal to 50% of the entities’ registered capital.  Appropriations to the statutory public welfare fund are at 5% to 10% of the after tax net income determined in accordance with the PRC GAAP.  The statutory public welfare fund is established for the purpose of providing employee facilities and other collective benefits to the employees and is non-distributable other than in liquidation.  Appropriations to the discretionary surplus reserve are made at the discretion of the Board of Directors.

 

During 2004 and 2003, the Company’s subsidiary, Harbin Hainan Kanda appropriated $236,708 and $185,614 respectively to the reserve funds based on its net income under PRC GAAP.

 

10.   RELATED PARTY TRANSACTIONS

 

The Company had advanced funds totaling $4,831 to a stockholder as of December 31, 2003 as a short-term, unsecured and interest-free loan.  This loan was fully repaid in 2004.  The Company had advanced funds totaling $845,411 and $809,179 to a related company as of December 31, 2004 and 2003 respectively, unsecured, interest-free loan and repayable on demand.

 

The Company owed $66,400 and $440,580 to stockholders as of December 31, 2004 and 2003 respectively as short-term, unsecured and interest-free loans.

 

11



 

11.   CONCENTRATIONS AND RISKS

 

During 2004 and 2003, 100% of the Company’s assets were located in China and 100% of the Company’s revenues were derived from companies located in China.

 

12.   SUBSEQUENT EVENT

 

(A)    Plan of reorganization

 

On May 13, 2005, pursuant to a Stock Purchase Agreement, InvestNet, Inc. (“InvestNet”) sold 30,000,000 shares to China Kangtai for $300,000.  On the same date, InvestNet entered into an Agreement and Plan of Reorganization with the shareholders of China Kangtai to exchange 110,130,615 shares of InvestNet for 12% of the issued and outstanding stock of China Kangtai .  In addition, InvestNet issued a Convertible Promissory Note for $8,070,000 due on October 28, 2005 (“the Note”) for the remaining 88% of China Kangtai.  The Note is convertible into 14,248,395 (post a one for seventy reverse split) shares of InvestNet.  The Agreement and Plan of Reorganization was completed on June 3, 2005.  As of August 15, 2005 the Note has not been exercised.

 

(B)     Change of the name of the Company subsidiary

 

On March 22, 2005, the Company’s subsidiary changed its name to Harbin Hainan Kangda Cacti Hygienical Foods Co., Ltd. (“Harbin Hainan Kangda”) and restructured as a limited liability company.

 

12